Maximising reach and engagement in lung cancer screening

Health screening helps detect issues early, often before symptoms appear, leading to better outcomes and less pressure on hospitals.   

The NHS Lung Cancer Screening Programme is a key part of the NHS’s shift from treatment to prevention, helping reduce health inequalities and improve survival rates through early detection. Xyla, part of Acacium Group, has partnered with Alliance Medical to deliver a nurse-led, patient-focused screening service across South Yorkshire and Bassetlaw, Lancashire and South Cumbria and Shropshire. 

The challenge

Lung cancer remains one of the leading causes of cancer-related deaths in the UK. The national screening programme targets individuals aged 55–74 with a history of smoking. Reaching underserved communities and re-engaging people who don’t respond to a request, especially those aged over 70, has proven difficult. 

Barriers such as digital exclusion, cultural and language differences and accessibility issues have limited uptake. Each area needed a solution that would maximise engagement and ensure no one missed the opportunity for life-saving early detection. 

Impact

Improved engagement and uptake

Xyla increased uptake among non-responders in Bassetlaw by 10%, with 22% of patients booking after receiving a GP-endorsed message. In Fylde & Wyre, the service achieved a 65% conversion rate from invitation to completed Lung Cancer Screening. These results demonstrate the effectiveness of personalised outreach, community engagement and use of a trusted messenger. 

Early cancer detection

The programme detected 763 cancers, including 266 lung cancers, most at early stages (1 & 2). Early diagnosis significantly improves survival rates and reduces the need for intensive treatment. This shift is helping transform outcomes for patients across the region.

High patient satisfaction

Over 97% of patients rated the service positively, citing professionalism, convenience, and compassionate care. Flexible scheduling and culturally sensitive support helped patients feel safe and respected throughout their journey.

Operational efficiency

Xyla managed over 35,000 appointments and responded to more than 28,000 patient queries. With a ‘did not attend’ (DNA) rate below 4%, the service delivered high throughput and consistent support. This streamlined model reduced pressure on NHS resources while maintaining quality care.